351 related articles for article (PubMed ID: 15201658)
1. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.
Levy G; Villamil F; Samuel D; Sanjuan F; Grazi GL; Wu Y; Marotta P; Boillot O; Muehlbacher F; Klintmalm G;
Transplantation; 2004 Jun; 77(11):1632-8. PubMed ID: 15201658
[TBL] [Abstract][Full Text] [Related]
2. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
6. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
Krämer BK; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Ortuño J; Sester U; Kunzendorf U; Dietl KH; Bonomini V; Rigotti P; Ronco C; Tabernero JM; Rivero M; Banas B; Mühlbacher F; Arias M; Montagnino G;
Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740
[TBL] [Abstract][Full Text] [Related]
8. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.
Vincenti F; Friman S; Scheuermann E; Rostaing L; Jenssen T; Campistol JM; Uchida K; Pescovitz MD; Marchetti P; Tuncer M; Citterio F; Wiecek A; Chadban S; El-Shahawy M; Budde K; Goto N;
Am J Transplant; 2007 Jun; 7(6):1506-14. PubMed ID: 17359512
[TBL] [Abstract][Full Text] [Related]
9. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.
Vincenti F; Tuncer M; Castagneto M; Klinger M; Friman S; Scheuermann EH; Wiecek A; Russ GR; Martinek A; Nonnast-Daniel B;
Transplant Proc; 2005 Mar; 37(2):1001-4. PubMed ID: 15848604
[TBL] [Abstract][Full Text] [Related]
10. Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).
Levy G; Burra P; Cavallari A; Duvoux C; Lake J; Mayer AD; Mies S; Pollard SG; Varo E; Villamil F; Johnston A
Transplantation; 2002 Mar; 73(6):953-9. PubMed ID: 11923699
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
12. Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients.
Briggs D; Dudley C; Pattison J; Pfeffer P; Salmela K; Rowe P; Tydén G;
Transplantation; 2003 Jun; 75(12):2058-63. PubMed ID: 12829912
[TBL] [Abstract][Full Text] [Related]
13. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
Jain A
Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-year observational results.
Krämer BK; Montagnino G; Krüger B; Margreiter R; Olbricht CJ; Marcen R; Sester U; Kunzendorf U; Dietl KH; Rigotti P; Ronco C; Hörsch S; Banas B; Mühlbacher F; Arias M;
Transpl Int; 2016 Mar; 29(3):307-14. PubMed ID: 26565071
[TBL] [Abstract][Full Text] [Related]
15. Comparison between C0 and C2 monitoring in de novo renal transplant recipients: retrospective analysis of a single-center experience.
Bîrsan T; Loinig C; Bodingbauer M; Wekerle T; Rockenschaub S; Berlakovich G; Soliman T; Mühlbacher F; Steininger R
Transplantation; 2004 Dec; 78(12):1787-91. PubMed ID: 15614152
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
Rolles K; Davidson BR; Burroughs AK
Transplantation; 1999 Oct; 68(8):1195-8. PubMed ID: 10551650
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP;
Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
Vincenti F; Rostaing L;
Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients.
Silva HT; Yang HC; Meier-Kriesche HU; Croy R; Holman J; Fitzsimmons WE; First MR
Transplantation; 2014 Mar; 97(6):636-41. PubMed ID: 24521771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
